THE IMPACT OF COVID-19 ON RANDOMIZED CLINICAL TRIALS
The COVID-19 pandemic has a major impact on the conduct of most on-going clinical trials, in particular on the treatment…
White papers
White papers
IDDI Comments on FDA Draft Guidance on Expansion Cohorts
The need to consider randomization whenever feasible in expansion cohorts The purpose of IDDI comments on FDA Draft guidance is to…